(Q53292199)

English

Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.

scientific article published on 7 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

1 reference

based on heuristic

inferred from title

adult-onset Still's disease

1 reference

based on heuristic

inferred from title

activation syndrome

1 reference

based on heuristic

inferred from title

macrophage activation syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Eimear Savage

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Tasheen Wazir

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Mary Drake

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Robert Cuthbert

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Gary Wright

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

publication date

7 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

53

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

1352-1353

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

Pathogenesis and management of adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU019

21 January 2018

Biological treatment in adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU019

21 January 2018

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU019

21 January 2018

Macrophage activation syndrome in autoimmune disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU019

21 January 2018

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU019

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEU019

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/24609056

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53292199&oldid=1532740294"